Steven T. Rosen
| Steven T. Rosen | |
|---|---|
| Born | New York City |
| Residence | Duarte, California |
| Alma mater | Northwestern University |
| Spouse(s) | Candice Polovina Rosen |
| Scientific career | |
| Fields | Oncology, Hematologic malignancies |
| Institutions | City of Hope National Medical Center, Northwestern University, National Cancer Institute |
 “Imerman Angels Partnership With City of Hope“, Imerman Angels |
|
|
“City of Hope: Robert Stone, Steven Rosen, and Stephen Forman on advances in cancer research”, Charlie Rose
|
Steven T. Rosen is the Provost and chief scientific officer of the City of Hope National Medical Center in Duarte, California. In addition to directing City of Hope’s Comprehensive Cancer Center, Rosen leads the Beckman Research Institute at City of Hope, and the Irell & Manella Graduate School of Biological Sciences. Previously (1989-2014) Rosen was the director of the Robert H. Lurie Comprehensive Cancer Center at Northwestern University, which was awarded comprehensive cancer center status by the National Cancer Institute (NCI) in 1997.
In 2015 Rosen received a lifetime achievement award from the Israel Cancer Research Fund (ICRF) for his work in cancer research. His main areas of research involve the development of new treatments, particularly for Hematologic malignancies.
Rosen received his bachelor's degree and medical degree with distinction (1976) from Northwestern University. He was a residenct in Internal Medicine at Northwestern. He was a fellow in Medical Oncology at the National Cancer Institute.
Rosen joined City of Hope on March 1, 2014 as its first provost and chief scientific officer. City of Hope has been a Comprehensive Cancer Center since 1998.
Before joining City of Hope, Rosen worked at Northwestern University. He joined Northwestern University in 1981 as a junior faculty member. He was the director of Northwestern University’s Robert H. Lurie Comprehensive Cancer Center from 1989-2014, and the Genevieve Teuton professor of medicine at the Feinberg School of Medicine. Beginning in 1993, the center at Northwestern received National Cancer Institute (NCI) funding as a designated cancer center in the United States. In 1997, it was awarded comprehensive cancer center status by NCI.
Rosen develops new treatments for cancer, working particularly with patients with hematologic malignancies. Major areas of focus for his research include 1) the mediation of cancer cell death by glucocorticoids in hematologic malignancies 2) the use of RNA-directed nucleoside analogs in cancer therapy and 3) the role of proteins in cancer metabolism. One of the nucleoside analogs he has worked on is in trials for the treatment of acute myeloid leukemia and chronic lymphocytic leukemia. Rosen has also worked to develop novel treatments for cutaneous lymphoma.
...
Wikipedia